ArticleBMC medical ethics2026
Return of health research findings in Nigeria-perspective of potential research participants.
Article in BMC medical ethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
backgroundHealth research in Nigeria, a low- and middle-income country with significant genetic diversity and disease burden, raises ethical challenges regarding the return of research findings to participants. Despite growing body of literature and ethical guidance on the return of health research findings, there is little empirical evidence on how the Nigerian public understands, values, and expects such feedback. Decisions about whether, what, and how to return results are often made without input from research participants or communities. This gap risks ethical misalignment, mistrust, and unintended harm, particularly in the context of limited healthcare access and social vulnerability. Understanding public perspectives is therefore essential to inform culturally appropriate, ethically defensible, and policy-relevant practices for returning research findings in Nigeria. This study explored the perspectives of potential research participants in Nigeria on the return of research findings-primary research results (RRs) and incidental findings (IFs)-,especially from human biological specimen (HBS)-based research.
methodsUsing a mixed-methods approach (quantitative and qualitative methods), a cross-sectional survey of 405 urban residents and focus group discussions involving 4 groups (gender/age stratified) with 30 participants were conducted within Enugu metropolis of Nigeria in 2021. The quantitative data was collected using a semi-structured, interviewer-administered questionnaire, and analyzed using Statistical Package for Social Science software program (IBM SPSS v.20 Inc., Chicago Il, USA). Researchers used descriptive statistics (frequencies and percentages) and chi-square tests to find connections between participants’ characteristics and their perspective on having research findings returned to them. A p-value of less than 0.05 was considered statistically significant. Manual thematic content analysis was used for the qualitative data.
resultsMost respondents (97%) desired the return of individual results, prioritizing actionable findings with clinical utility. Many struggled to distinguish between RRs and IFs, indicating a potential misunderstanding of nature and limitations of different research findings. The study revealed a strong trust in researchers but also highlighted misconceptions about the distinction between health research and healthcare. In the binary logistic regression model, trust in health researchers was the only significant predictor of the likelihood of desiring the return of health research findings, while age, education, and marital status showed no meaningful associations. Preferences for in-person disclosure were driven by concerns over confidentiality. Key barriers included inadequate funding, logistical challenges, and low health literacy. Participants recommended measures such as increased funding, training for researchers, and culturally sensitive policies to address these challenges.
conclusionThe findings underscore strong community demand for the return of individual research results, especially clinically actionable information, but also reveal critical gaps in understanding, resources, and infrastructure. Addressing misconceptions, safeguarding confidentiality, and implementing culturally sensitive, well-funded strategies are essential to ensure ethical and effective return of results in health research. CLINICAL TRIAL NUMBER: Not Applicable
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.